Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab with platinum-pemetrexed with or without bevacizumab in advanced non-squamous NSCLC (WJOG11218L)
jRCT2080224500Phase 3Completed
- Sponsor
- Isamu Okamoto
- Start
- Jan 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of atezolizumab in Non-small cell lung cancer (NS-NSCLC) (2 arms), sponsored by Isamu Okamoto. Started Jan 2019; status: completed.
02
Drugs
atezolizumab
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on jRCT2080224500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224500.